A good set of teeth makes all the difference, not just for the purpose of smiling, but it also has a huge impact on self-esteem and overall confidence. Having broken, missing or unsightly looking teeth makes it hard for people to express themselves effectively and clearly.
As more and more people are realizing the importance of dental health and its impact on their lives, whether at a personal or professional level, an increasing number of people are also deciding to get dentures, dental implants, braces and other dental appliances.
With this in mind, it is not surprising to know that according to the American Academy of Implant Dentistry, the dental implant and prosthetic business in the United States is projected to reach a lucrative estimate of $6.4 billion by the end of 2018.
The dental implant industry has been consistent in making breakthroughs and finding more innovative ways to improve the overall quality and standards of its products. Indeed, the recent developments in dental technology make getting dental implants more and more attractive for consumers. Here are just some of the most recent innovations in the field of implant dentistry.
Computer-designed implants
For every dental implant procedure, the ultimate goal is to have satisfactory bone stability. This is because with the current state of dental technology, crestal bone loss is still an unavoidable result. As a consequence, bone resorption and/or bone loss still poses a threat to successful dental implants, especially to short dental implants.
With this ultimate goal in mind, clinicians and dental practitioners have long researched different approaches that can be taken to avoid bone loss. According to recent studies, a new development is now seeing the light, with dental implants that can encourage zero bone loss with the usage of computer aided design and computer aided manufacturing (CAD-CAM).
This technology aims to create exact duplicates of the missing teeth which can immediately be replaced in the mouth. Once the defective biological tooth comes out, the replica is then placed in the empty space. The best thing about this technology is that it offers patients a symptom-free healing process, which also in turn is advantageous for dentists as it gives them a more effective and efficient way to create dental implants.
Disease and illness are running wild these days and individuals are more aware than ever of the need to make lifestyle changes. There has been an increase in the number of people who are interested in getting educated about their health and ways to improve it. Beyond dieting, exercising, and getting enough sleep, patients are digging deeper to find out what’s going on.
To know what’s going on, one must first have a clear understanding of their family history. While some may know of a few generations and medical histories, many are clueless as to their bloodline and how it can impact their health or efforts to improve. Fortunately, modern technology has made it possible for individuals to have a clearer picture.
DNA tests for family history and its increased accessibility to the average consumers have cultivated a new method for improving health and wellness. With a full breakdown of a person’s genetic makeup, medical providers and private companies are able to learn a lot about an individual and what steps need to be taken to enhance their well-being. Here’s a look at some of the data derived from DNA testing:
Dietary Options – When it comes to eating right, what works for one individual may not work for another. Genetic testing can give patients insight on what they should and shouldn’t be eating. Results can conclude things like how much protein a person should eat, which fats are best, your food sensitivities, nutritional deficiencies, and the types and how much carbs you should be consuming.
Disease Risks – It is believed that there are some genetic components tied to the development of certain diseases like high blood pressure, diabetes, osteoarthritis, cancer, and more. Advanced DNA tests, however, now reveal whether or not a patient is at risk of developing certain diseases based on their genetic coding. This knowledge can help patients to get proactive and start making more efficient changes to their lives to prevent the diseases.
Weight Management – Not every patient is successful in losing weight simply by eating good foods and exercising. For some, there is a genetic link that hinders them. Whether it be the love of sweets, addictive traits, some underlying disease relating to weight, or a family history of obesity, it can be discovered through DNA testing. Armed with this information patients can then make more effective decisions and get support in areas they weren’t aware they needed it to finally shed the pounds and keep them off.
Efficient Medicine – From treating mental illness to life-threatening diseases, doctors rely on modern medicine to help improve the lives of their patients. However, as with most things, what works for one patient may not be as effective for another. DNA testing, however, changes that because they now have a clear picture of their patient’s genetic makeup and how it is impacted by certain medications. This provides healthcare providers with a more accurate means for prescribing the right medication and dosage with fewer side effects and more effective results for their patients.
Thanks to the advancements of modern technology like DNA testing healthcare providers and their patients are equipped with data that can increase the quality of life. Though it is still crucial to be observant, eat right, exercise and take medications as prescribed, the use of such data makes it possible to get more detailed in each category on what will work most effectively for each person. This reduces the risk of disease, enhances treatment options, and reduces the unhealthy state of patient health today.
By Jayne Warwick, director of market insights, PointClickCare.
The Patient Driven Payment Model (PDPM) is more than just a new name attached to Medicare payment reform. The shift from Resource Utilization Group (RUG) IV to PDPM moves the skilled nursing reimbursement model away from therapy provision as its main driver. Instead, payment will be determined by the provision of nursing care with higher rates being attached to more clinically complex patients.
PDPM will also align reimbursement with the industry-wide shift to value-based care (as opposed to volume).
It is designed to:
Incentivize treating the needs of the whole patient
Refocus care on good clinical practices
Decrease focus on the volume of services that the patient receives
Reduce administrative burden on the provider
Why do we need it?
The skilled nursing industry has advocated for payment reform for years. In response to requirements in the IMPACT act of 2014 and the resulting PAMA act, post-acute care must have a unified prospective payment system by 2024. Different post-acute settings use different data to determine payment. PDPM is the beginning of unifying the data tied to reimbursement.
In addition, the Medicare Payment Advisory Commission (MedPAC) and the Office of the Inspector General criticized the current RUG IV system for incentivizing therapy over the provision of clinical care. Essentially, the more therapy minutes provided, the higher a skilled nursing facility would be reimbursed. Since the majority of minimum data sets (MDS) that were submitted in the highest RUGs categories were within five minutes of the 720-minute threshold, the RUG IV system was scrutinized for promoting the threshold as a goal for care, rather than the outcomes of the therapy.
Also, RUG IV has been criticized for its strenuous administrative requirements. Providers needed to complete many assessments for a single Medicare A stay. For many years, CMS has been under pressure to reduce the administrative burden associated with RUG IV.
These factors illustrate the need to link reimbursement to patient need, as well as the imperative to focus on good clinical care.
Timeline
The Resident Classification System, Version 1 (RCS-1), was proposed in May 2017. In May 2018, RCS-1 was replaced with PDPM. It was finalized on July 31, 2018 and will go into effect on October 1, 2019.
Benefits
A reduction in scheduled PPS assessments from five to one required assessment and only two unscheduled assessments, the IPA and the Discharge PPS assessment
More focus on the clinical characteristics of the resident
Utilization of ICD-10-CM documentation to drive reimbursement process for therapies and non-therapy ancillaries
Opportunity to increase reimbursement with proper co-morbidity capture
Shifting resident population away from rehab-intensive focus to more clinically focused care
How you can start preparing now
To adequately prepare for PDPM, there are several activities facilities can begin performing to ready themselves for the transition. These steps to change management for PDPM will help any facility succeed through the immediate shift in payment. They will also strongly position a facility to readily adapt to future payment reforms or shifts that may be imposed as all payors transition to the PDPM methodology.
To start, facilities need to understand the plan and the financial, cultural and operational impact it will have on their business. Providers need to consider their current state, as well as areas they want to be successful in once PDPM goes into effect. Homes should be looking at staff skills and competencies to support the shift to a more clinically driven patient population and determine where changes, education, or upskill training is required.
Facilities need to understand the impact of the conversion. For example, will they have the right mix of residents and needs to support revenue goals? This is also the time homes should examine how they capture required documentation and ICD-10 coding practices. Do they have the right information to code appropriately? To get the right code? To accurately code the MDS? This is the foundation for being successful with PDPM.
After facilities understand PDPM and its impact on their business, it is crucial that they standardize their processes and content to capture the right data elements. This will better enable facilities to gain insights into what else they may need to change to be successful, as well as identify gaps, level the playing field for staff care provision, and make possible the measurement of expected outcomes against actual outcomes. This standardization will also serve homes well in the future. PDPM affects Medicare A residents in 2019, but when CMS retires the PPS item set in 2020, homes that have mastered the move to standardization will find the shift to PDPM for all payers much smoother.
By Amy Sklar, SVP of advanced manufacturing communities, UBM.
As reported by Rock Health’s Midyear Funding Review, 2018 got off to a roaring start with $3.4 billion for digital health funding in the first six months of the year. All indicators point to continued momentum in 2019, as startups and veteran companies alike work to unlock the potential of digital health technology to increase efficiencies in healthcare delivery and improve patient outcomes.
In the coming year we will see innovations including smart, connected products offering opportunities for new functionality, consumer engagement, and higher product utilization. The industry will additionally see startups enter the space leveraging new capabilities for data collection and analytics to better apply insights to make medicine more precise. To learn more, a panel of experts will expand on this topic, speaking to the evolving nature of digital health at MD&M West Anaheim 2019.
Miniaturization
While nanotechnology isn’t anything new, we will see continued interest in developing the space with an anticipated move toward more catheter-based and minimally invasive procedures. Medical devices are getting smaller with the demand for technology-driven advancements, and rapid developments are being made in design options to enable drug delivery. In particular, breakthroughs in new drugs and biologics are increasingly seeking localized delivery for better therapeutic effects.
Surgical robotics
Medical robotics has an exciting future. At the Medical Design and Manufacturing (MD&M) 2019 conference in Anaheim, we are seeing a significant increase in companies impacting the surgical robotics field. A few key players include Intuitive Surgical, TransEnterix, Medrobotics, Medtronic with its acquisition of Mazor Robotics and Neural Analytics. Robotic-assisted surgery has the potential to improve patient care and vastly increase the efficiency and accuracy of healthcare teams. We are entering a world where surgical robots are more than just a robotic arm. It consists of intraoperative-imaging, surgical navigation, 3D imaging, pre-surgical planning software, among others, that all mesh seamlessly into the surgeon’s workflow to enable improved outcomes.
Augmented reality and virtual reality: Changing the face of healthcare
One of the most exciting areas of development in the medical technology arena is augmented and virtual reality. While augmented reality (AR) and virtual reality (VR) have a variety of benefits, we will see these technologies expanding access to healthcare in 2019. Telemedicine is still in its infancy, but with population health on the forefront of medical technology conversations, 2019 will see major strides in advancing virtual care to support the two thirds of the world’s population that doesn’t have access to safe or affordable surgery.
The technology available to diagnose and treat a wide variety of illnesses and ailments continues to improve with every year. While these developments are undoubtedly contributing to increased rates of recovery and preferred patient outcomes, doctors and other medical professionals continue to rely on a relatively basic set of guiding principles when determining the probable causes of disease and the best methods of treatment.
Simply put, physicians learn to pay attention to their patients and watch closely for the signs and symptoms of various illnesses and ailments. More times than not, a trained doctor can make an accurate diagnosis based on physical examination and conversation.
With this in mind, regular folks can easily improve their ability to monitor loved ones for signs of illness by simply improving their observational skills. While we do not advocate for armchair diagnosis — the opinion of a licensed physician is always recommended — the ability to pay attention to the right clues can go a long way in making sure you and those around you are not turning a blind eye to something serious.
For instance, if you’re married to someone who suffered from alcohol or drug dependence in the past, there may be numerous telltale indications of relapse. According to a leading center for drug rehab in Georgia, addicts often retreat from the people in their lives. They often start making excuses for things and neglecting their responsibilities. They often become alienated from their relatives and from society in general. If your husband or wife behaves oddly any time he or she consumes alcohol, then that may denote an issue with alcohol addiction. Addiction to alcohol is a problem that plagues people all around the globe. It plagues people young and old as well. Pinpointing common signs of addiction can do a lot for people who want to help their loved ones nip serious issues in the bud.
With AI increasingly playing a role in healthcare, and the cost of insurance continuing to rise, it’s no surprise that people might be feeling a little bit disillusioned and confused as to what to expect this year. However, as the pace of technology continues to accelerate, as does the political situation, it’s all the more reason to keep a sharp focus on where the technology and healthcare in general is heading.
Last year, the new Apple Watch proved that it could potentially save lives by offering an ECG function, and Google has, of course, acquired its own technology with DeepMind. While Facebook had previously dipped its toe in the market with plans of sharing data with health organizations, it has pulled its ambitions after concerns over its use of user data.
Amazon to be involved with healthcare
We all use Amazon for last-minute Christmas presents, book wish-lists and the odd bits and bobs, and Amazon Prime has proven to be a hit among its regular customers. Citi analyst Mark Mary predicted that their subscribers will reach 275 million, up from 101 million at the end of 2017. With that in mind, it might not necessarily come as a surprise that Amazon Prime will not only continue to exist and grow in its current form, but also for healthcare. According to Anurag Gupta, a VP at tech analyst Gartner: “Amazon likes to target two kinds of industry: the first is where they see an opportunity to reform, where it’s not the most user friendly of industries, where there’s a lack of trust. In the case of healthcare, intermediaries like pharmacy benefit managers, drug wholesalers and distributors are ‘sucking a lot of money out of the system.'”
According to Gupta, the reason a lot of big tech industries have such a big focus on healthcare is because, like any commercial business, they have their eyes on any holes in the current market. Unfortunately, the current gap appears to be customer service. Giants like Amazon have experience in customer service where some healthcare brands don’t, which means they are quickly honing in on that market.
According to ZD.net, Amazon Web Services is planning on extending its Comprehend language processing service to medical records. It reported that in a blog post, Amazon Web Services claimed that it was also planning on building a new version that could account for “medical terms, anatomy, conditions, medications and various healthcare terms.” The news site also reported that Amazon had also acquired PillPack, a company that delivers medicines to people’s doors and refills their prescriptions.
Although Amazon isn’t the first to join this market, they certainly seem to be getting everything in order to correspond with their other services.
Petitions to end work-based health insurance
Although half of all Americans get their health insurance through their employers, this still leaves half of US citizens having to cover the costs themselves. Some US citizens even have to take on two or more jobs or get help from wealthier relatives to cover the cost. More than ever, people are campaigning for this to end, as it currently stands as a block (with the exclusion of the current government) to people from potentially receiving healthcare from the government. For those enjoying the benefits of full-time employment and an employer that covers them, 83 percent said their insurance was excellent or good. For those who are not sponsored by an employer for their healthcare, unexpected emergencies can be costly. Investigating alternative finance options and research may be the best option for some.
IBM continues to push Watson
IBM’s CEO Ginni Rometty announced in an interview in January that IBM Watson Health is still “a very important part” of their business. Rometty re-iterated how well their oncology software after it was seemingly being publically criticized for not being up to scratch. She insisted on Watson’s success during a Keynote speech at the Consumer Electronics Show in Las Vegas, despite turning down interviews with other magazines.
STAT news reported some alarming quotes from IBM’s health division, as well as a number of employee layoffs. A big criticism of this software that recommends cancer treatments is that it prioritizes American treatment methods. That said, IBM has reportedly said that it plans to add regional treatment guidelines as well as some expanded real-world data on patient outcomes.
Healthcare organizations face unprecedented compliance challenges when it comes to managing business associate agreements (BAAs) amid frequent data breaches, heightened federal scrutiny and anticipated privacy legislation. Actions by the Office for Civil Rights (OCR) have clearly demonstrated stricter enforcement of HIPAA rules in recent years, and the industry has already witnessed a notable uptick in public shaming and fines associated with missing just a single BAA.
In December 2018 alone, OCR announced two notable settlements. Advanced Care Hospitalists (FL) entered into a $500,000 no-fault settlement with OCR, and Pagosa Springs Medical Center (CO) agreed to pay $111,400, both for missing a single BAA.
Simply put, BAAs have become a cornerstone of OCR compliance initiatives. And the outlook is not likely to change as trends point to continued advancement of privacy laws. As of close of 2018, 12 states had already updated their privacy laws regarding notification to patients, shortening the standard 60 days from the federal guidelines to 45 days, and in some states (CO, FL), the breach notification window is down to 30 days.
Breaches involving protected health information (PHI) are typically reported publicly at the Covered Entity (CE) level. When a breach involving a third party, or Business Associate (BA), occurs, one of the first things the federal government investigates is whether a BAA is in place with the CE. If a BAA does not exist, it typically sets off a chain reaction of investigations into other areas of HIPAA compliance.
While most headlines related to BAA compliance relate to CEs, HIPAA experts predict that 2019 will usher in greater focus on BAs and their management of these agreements as well. Many believe that unprepared BAs—especially small and mid-sized companies that lack resources to address HIPAA compliance—will become targets, increasing industry concern over proper BAA compliance.
Healthcare’s BAA management conundrum
Today’s healthcare organizations are feeling the heat, yet most are challenged to effectively manage BAAs due to limited resources for reviewing and managing massive and growing numbers of these agreements—reaching upwards of several thousand in larger organizations and health systems. Exacerbating this challenge is the current consolidation trend, which creates a fragmented landscape for BAA oversight that extends across multiple departments, facilities, affiliations and a multitude of different owners.
Consequently, manual, inconsistent workflows common to BAA management in today’s organizations open the door to significant risk. In truth, the most basic information often eludes the executive suite in most CEs and BAs, including the total number of existing agreements, where they are located and the terms of each.
BAAs are also the subject of intense negotiations between CEs, BAs and other subcontractors that often result in obligations that go beyond HIPAA and HITECH, causing contractual obligations to vary significantly between agreements. Subsequently, when organizations need to know the terms of these agreements, they must manually extract the information one agreement at a time. Within a framework of manual processes, the resources required to conduct this kind of data extraction across hundreds or thousands of BAAs is simply unfeasible for many organizations.
Yet, compliance professionals need quick and easy access to this information to ensure optimal response to breaches, which have become the norm for healthcare organizations as opposed to the exception. Consider the findings of a 2018 Black Book Market Research study: 90 percent of healthcare organizations have experienced a data breach since the third quarter of 2016, and nearly 50 percent have had more than five.
By Ken Perez, vice president of healthcare policy, Omnicell.
The 340B Drug Pricing Program was created in 1992 to give safety net providers — those that deliver a significant level of both healthcare and other health-related services to the uninsured, Medicaid, and other vulnerable populations — discounts on outpatient drugs to “stretch scare federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” In brief, the program requires drug makers participating in Medicaid and Medicare Part B to provide discounts on outpatient drugs to 340B providers, which include various types of hospitals and certain federal grantees, such as federally qualified health centers and comprehensive hemophilia treatment centers.
For years, the 340B program has been fraught with controversy, with concerns raised about the program’s lack of accountability and oversight, and findings of widespread diversion of benefits (discounted drugs) to ineligible patients.
The nonpartisan Medicare Payment Advisory Committee (MedPAC) found that hospitals in the 340B program receive a minimum discount of 22.5 percent of Average Sales Price (ASP) for drugs paid under the Medicare Hospital Outpatient Prospective Payment System (OPPS). The Office of the Inspector General of the U.S. Department of Health and Human Services (HHS) found that the average 340B discount was 34 percent of ASP, and at least two organizations with 340B members estimated that 340B discounts could be as high as 50 percent of ASP.
Based in part on these findings, in 2017 HHS proposed and finalized a rule implementing a sharp reduction in 340B reimbursement of hospitals by the Centers for Medicare and Medicaid Services from ASP plus 6 percent to ASP minus 22.5 percent, along with an offsetting payment rate increase for non-drug items and services. It was estimated that 85 percent of 340B hospitals would see overall net payment increases in 2018 as a result of these changes, and that 340B hospitals would continue to benefit financially from the program.
Nevertheless, the American Hospital Association (AHA), America’s Essential Hospitals, and the Association of American Medical Colleges—all non-profit hospital associations—filed suits against HHS to block the change.
On Dec. 27, 2018, Washington, D.C. federal district court judge Rudolph Contreras (a Democrat nominated by President Barack Obama), issued a 36-page ruling in favor of the AHA, et al. and struck down the 340B payment reduction, contending that HHS Secretary Alex Azar exceeded his statutory authority by issuing a policy that would “fundamentally rework the statutory scheme.”
Contreras issued a permanent injunction of the new reimbursement policy, but he did not grant the plaintiff’s request for retroactive OPPS payments based on the original reimbursement formula. (HHS is unable to come up with the monies to pay back the hospitals, as they have already been spent.) Contreras ruled that the plaintiffs “are entitled to some relief,” but, recognizing “the potentially drastic impact of …[his] decision on Medicare’s complex administration,” he ordered a supplemental briefing to come to a “proper remedy.”